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With the ever-growing pandemic of obesity comes a multitude of consequential 
morbidities, such as increased risk of heart disease and type II Diabetes Mellitus. 
Secondary to diabetes is diabetic neuropathy, the regression or dying back of nerves that 
often occurs in the extremities, leading to loss of sensation or pain. Additionally, aging is 
a risk factor for obesity, diabetes, and neuropathy. Responsible for the communication 
between the extremities and peripheral tissues, such as adipose (fat), and the brain, is the 
peripheral nervous system. The peripheral nervous system is the umbrella under which 
varying types of nerves are designated, including sympathetic, parasympathetic, and 
sensory nerves, which have been shown to innervate adipose tissue.  Both the peripheral 
nervous system (PNS) and central nervous system (CNS) house glial cells, whose 
neuron-supporting functions are vital for maintaining homeostasis. Oligodendrocytes are 
the myelin-forming cells of the CNS, while Schwann cells are the myelin-forming cells 
of the PNS. Myelin is a fatty substance that ensheaths the axons of neurons, insulating 
them and allowing signals to be propagated through the body faster. Whereas crosstalk 
between glia and the immune system in the CNS is of increasing popularity in current 
research, much less is known about relative roles of glia and local immune cells in the 
PNS, particularly in adipose. This thesis delves into further investigating the types of glia 
that may be present in and interact with adipose tissue nerves. A better understanding of 
this interaction in adipose will be beneficial in uncovering mechanisms of proper energy 
balance and metabolic health, as well as potentially mitigating the progression of diabetic 
  
neuropathy, or the death of peripheral nerves.  To our knowledge, this thesis investigates 
the first ever immunopanning experiments for Schwann cells in adipose tissue.
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 The obesity epidemic is rapidly ever-growing around the world despite the 
increased recognition of the problem and its associated health risks. Adults having a body 
mass index (BMI) of 25.0 kg/m2 to 29.9 kg/m2 are defined as overweight, while those 
with a BMI of 30 kg/m2  or higher are defined as obese[1]. According to the World 
Health Organization, worldwide obesity is nearly three times what it was in 1975, with a 
reported number of 650 million obese adults[2]. The issue at hand does not solely affect 
adults, however, and has had major implications in children as well. Children and 
adolescents from the ages of 2 to 18 are defined as overweight if they are in the 85th to 
94th percentile of the population for their sex and age, and defined as obese if at or above 
the 95th percentile[1]. Since the year 2000, the number of overweight children under the 
age of 5 in Africa has increased by roughly 50 percent, while in 2016, half of the world’s 
overweight or obese population of children under the age of 5 lived in Asia[2]. Once a 
more drastic problem in high-income households, obesity has infiltrated into low- and 
middle-income households and countries as well.  
Factors worldwide that have contributed in countries of all economic statuses 
include, but are not limited to, foods that are higher in sugar, fat, and salt, yet lack 
nutrients, inadequate amounts of sleep, chronic stress, eating while on-the-go, the 
increase in sedentary jobs as a result of technological advances and therefore decreased 
physical activity, and various levels of urbanization (i.e. more efficient transportation in 
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highly populated areas)[2,3]. In addition to the growing issue around the globe, the 
United States has also been greatly impacted by this epidemic. Prevalence estimates 
based on self-reported obesity published by the Centers for Disease Control and 
Prevention (CDC) showed that in 2011, all fifty states had an obesity prevalence of less 
than 35% and eleven states had a prevalence between 20%-25%. By 2018, however, self-
reported obesity rates drastically increased, leaving nine states with an obesity prevalence 
of over 35% and only three states with a prevalence between 20%-25%[4]. In New 
England, Maine remains the state with the highest rate of obesity, which could be in 




 The human body composition largely depends on the balance between energy 
input versus energy expenditure. Factors that may be characterized as energy intake 
include diet, appetite, and digestion and nutrient absorption, while those characterized as 
energy expenditure may include basal metabolism, thermogenesis, and exercise/physical 
activity. As attributes on the energy intake side of the balance, such as diet, begin to 
outweigh energy expenditure, complications such as obesity begin to arise as a result. 
Individuals are subject to developing obesity based on varying factors, including sex, 
environment, genetics, age, and differences in the types of adipose tissue present[5,6]. 
Along with obesity comes the increased risk for comorbidities, some of which 
include stroke, hypertension, some cancers, and type 2 diabetes[1]. Of these, type 2 
diabetes is one of the most common results of obesity. According to the American 
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Diabetes Association, “diabetes mellitus is a group of metabolic diseases characterized by 
hyperglycemia,” or increased blood sugar[7]. This sugar, or glucose, is a vital aspect in 
the body’s metabolic health. When there is a normal glycemic index, the body is healthy 
and able to carry out its functions. When there is an increased level of glucose in the 
blood for extended periods of time, however, metabolic complications can begin to arise.  
 Type 2 diabetes has historically been diagnosed mostly in adults, although the 
number of children and adolescents being diagnosed with type 2 diabetes over the past 
decade has increased drastically. Insulin is a hormone that is produced by the beta cells of 
the pancreas and is responsible for the uptake of glucose from circulating blood into the 
body’s cells. Therefore, glucose and insulin have an inverse relationship in a healthy 
individual, where a high level of glucose means there is currently a low level of insulin, 
and a high level of insulin would lead to lower levels of circulating glucose. Type 1 
diabetes is the result of an autoimmune response in which the immune system mistakenly 
attacks the insulin-producing beta cells and thus the body is unable to make normal 
amounts of insulin[8]. This generally leads to such minute amounts of insulin in the body 
that individuals affected need to take insulin in order to survive. Type 2 diabetes is 
generally the result of prolonged, excessively high blood sugar levels. In this scenario, 
the beta cells of the pancreas try to make insulin to overcompensate for the high blood 
sugar levels. Eventually, the pancreas is unable to keep up with the amount of glucose 
and insulin resistance develops[8]. Nearly 85%-95% of all diabetic patients in high-
income countries around the globe are diagnosed as type 2 diabetic patients, with the 
potential that the rate is even higher in low-income countries[9]. 
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Diabetic Peripheral Neuropathy 
 Peripheral neuropathy is an unfortunately common consequence of patients 
diagnosed with diabetes. Peripheral neuropathy refers to physiological damage occurring 
in the peripheral nerve that is commonly presented in patients as distal degenerative 
polyneuropathy beginning in the extremities[10,11]. Roughly 20% of patients with type 2 
diabetes will have diabetic peripheral neuropathy at initial diabetes diagnosis, and about 
50% of all diabetic patients will inevitable develop diabetic peripheral neuropathy 
(DPN)[11,12]. DPN can have devastating effects on the lives of the patients effected and 
have a variety of implications. For instance, the regression of the nerve health can lead to 
loss of sensation and/or pain, which can in turn lead to much larger life-altering changes 
such as gait disturbance, fall-related injuries, and the development of ulcers on the feet, 
frequently a preempting lower limb amputation[11].  
 There are various categories of DPN, with the most common being distal 
symmetric polyneuropathy. This type of DPN constitutes nearly 75% of all diabetic 
neuropathies and can be characterized in one of three ways; primarily small-fiber, 
primarily large-fiber, or a combination of the two[12]. The remaining approximate 25% 
of diabetic neuropathies include categories such as treatment-induced neuropathies, 
mononeuropathies, and autonomic neuropathies – the most similar to distal symmetric 
polyneuropathy despite being mostly non-sensory[12]. There are currently no treatments 
for neuropathy, only medications prescribed in hopes of making patients more 
comfortable, weight management, blood glucose control, and physical therapy[11,12]. 
 A lot of aspects contribute to the peripheral nerve not maintaining its proper 
function. The cell body is housed just outside of the spinal cord in what is called the 
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dorsal root ganglion (DRG) or anterior horn cell, and this is where damage can often 
begin. The damage can then progress through the rest of the cell and axonal projection, 
including the myelin sheath wrapped around it[11]. In patients with diabetes, the 
endoneurial microvessels are damaged and therefore cause structural abnormalities in 
diabetic nerves[13]. A decrease in the thickness of the basement membrane of these 
endoneurial microvessels has also shown to be correlated to decreased myelinated fiber 
density[13]. Excessive glycation is common in diabetic nerves, and advanced glycation 
end-products (AGE) deposition in various structures of peripheral nerve tissues, 
including the axoplasms of Schwann cells, presents an inverse correlation with 
myelinated nerve fiber density. In fact, diabetic mice without the gene for the receptor for 
AGE (RAGE), have shown protection against neuropathy[13]. Sustained hyperglycemia 
leads to oxidative stress and thus the generation of free radicals, eventually causing 
mitochondrial damage and leading to downstream effects of reduced neurotrophin-3 (NT-
3) and nerve growth factor (NGF)[13]. Large-fiber DPN causes patients to be particularly 
susceptible to developing foot ulcerations as a result of the loss of sensation in the foot as 
well as gait disturbance. Common symptoms often described by the population of 
patients with this type of neuropathy are numbness, tingling, and discomfort[11].  This is 
a consequence of the “large-diameter myelinated A-beta somatic fibers” being affected 
by (generally longstanding) neuropathy, because these fibers are notorious for their role 
in touch sensation and joint position[11]. In comparison, small-fiber DPN affects mainly 
“small diameter thinly myelinated A-delta fibers” and “unmyelinated C somatic fibers” 
responsible for transmission of cold/mechanical pain information, and thermal, 
mechanical, and chemical pain signals respectively[11]. As a result, patients often 
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complain of painful sensations such as burning and stinging and present with minimal 
ability to sense external painful and thermal stimuli in conjunction with decreased 
proprioceptive sensation[11]. 
 
Nerve Innervation and Neuropathy in Adipose Tissue 
 In order to maintain a healthy metabolic balance, the exchange of information 
between the brain, particularly the hypothalamus, and peripheral tissues is critical. 
Communication to the brain from the periphery is not only signals sent from circulating 
nutrients and endocrine factors, but also consists of signals from afferent sensory nerves 
and efferent sympathetic nerves relaying information to and from the periphery[14].  
There are two major divisions of adipose, or fat; brown adipose tissue (BAT) and 
white adipose tissue (WAT). While WAT is notorious for its role as the major site of 
energy storage, BAT is predominantly known for its thermogenic and energy expenditure 
function[5]. It is known that BAT is in relatively high abundance in newborns, but 
prevalent in lower amounts of adult humans. Recent research has revealed, however, that 
brown adipogenesis can be induced in white fat through various physiological stimuli, 
including cold exposure and sympathetic activation[15]. Additionally, adipose tissue is 
responsible for secreting various circulating endocrine factors that contribute to the 
activation of lipolysis in WAT or thermogenesis in BAT[19]. An example of this is the 
release of norepinephrine by sympathetic nerve terminals as a positive regulator of 
lipolysis. For these reasons, it is typical for an excess of WAT to be associated with the 
obesity epidemic and fat accumulation, while BAT or the browning of white adipose 
tissue could contribute to the protection against obesity. One of the major defining 
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characteristics of obesity is an increase in fat cell number, making it important to 
understand the processes under which this may occur, or how it may be affecting other 
physiological processes[16]. Browning and adipocyte mass homeostasis are largely 
dependent on nerve supply to the WAT. The sympathetic nervous system (SNS) is known 
for conveying energy expenditure signals from the CNS to peripheral tissues[17]. 
Surgical denervation of SNS fibers in WAT has been shown to increase the number of 
adipose cells and thus increase fat pad mass, although there was no increase in the size of 
the fat cells themselves[16,18]. SNS innervation of WAT is known for its role in 
modulating fat cell proliferation through the release of norepinephrine (NE) that acts to 
inhibit fat cells from proliferating freely[18]. This result differs from that of strictly 
sensory denervation that shows an increase in the size of fat cells, but no change in 
overall fat pad mass[18]. This notable difference is important for investigating the 
different roles of both sensory and sympathetic innervation in white adipose tissue, and 
their contribution to maintaining proper energy balance.  
 Historically, peripheral neuropathy has been noted as a metabolic disease in 
tissues such as that of the skin and distal extremities, but it has more recently been shown 
to have other implications and occur in various other organs, including adipose. While 
there is a continued need for further study in metabolic functions and mechanisms, it has 
been shown in a cohort of experiments including aging, obesity, and diabetes, that WAT 
from both mice and humans fails to maintain healthy innervation[17]. Failure to maintain 
proper innervation can have serious implications in the energy balance roles of the nerve 
fibers affected, as we know these nerves are responsible for processes such as lipolysis 
(releasing fatty acids through the breakdown of fats) and thermogenesis (the generation 
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of heat, particularly in BAT due to UCP-1)[17]. Leptin, a hormone produced by adipose 
tissue, is responsible for the breakdown of white adipose tissue via its communication 
with the brain. This lipolytic effect is knowingly modulated by sympathetic nerve 
fibers[20]. Thus, denervation of sympathetic nerves in adipose tissue can also have 
detrimental effects to the tissue’s health.  
Such findings further the necessity for looking into possible solutions and 
treatments for neuropathy, particularly that of adipose tissue. Using an axonal growth 
cone marker (GAP43), a pan-neuronal marker (PGP9.5), and a sympathetic nerve marker 
(tyrosine hydroxylase or TH), it has been depicted that cold exposure intervention 
enhances nerve plasticity in the peripheral adipose tissue[17]. Cold exposure 
interventions in visceral adipose tissue (VAT) have also been shown to induce significant 
weight loss in mice fed high-fat diets (HFD), as well as significant increase of metabolic 
responses, and the remodeling of the adipose[21]. This remodeling in subcutaneous WAT 
involves the increase in sympathetic fiber innervation shown through expression of 
tyrosine hydroxylase (TH), a common dopaminergic marker, as well as pan-neuronal 
marker TUBB3. Other factors that contributed to the adipose remodeling were 
angiogenesis, browning of the adipose tissue, and an induced accumulation of 
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Risk of Neuropathy Increases with Age 
 According to the U.S. Census Bureau, Vintage 2018 Population Estimates, Maine 
has the highest population percentage of individuals sixty-five or older in the nation[22]. 
Aging individuals are at higher risk for the development of type 2 diabetes and therefore 
the development of neuropathy. The level of risk and severity for the development of 
diabetic neuropathy in an aged population is dependent upon a plethora of factors, 
including hyperglycemia, hypertension, and smoking[23]. PGP9.5, a pan-neuronal 
marker, exemplifies a significant decrease in inguinal subcutaneous WAT of both mice 
and humans is seen as age increases, indicating the severe loss of nerve innervation in 
this tissue[17]. Additionally, increased age in mice correlated with a trend for increased 
subcutaneous WAT weight and a trend for decreased levels of the SNS marker, TH[17]. 
Aged populations with diabetic neuropathy are also at a high risk of exhibiting 
microvascular complications, as well as decreased innervation surrounding the 
vasculature in their subcutaneous WAT depots[17,23]. Loss of proper vascular function 
could be a crucial factor, as it signifies loss of well-distributed nutrients to the affected 
regions.  
The Importance of Glia in Nerve Health 
 Glia are a crucial component of the neurological system as they are 
characteristically known as the neuronal support cells. The word “glia” is derived from 
the Greek word for “glue,” which is fitting given the function of these cells[24]. There 
are various types of glia throughout the body, with unique types in varying niches. For 
instance, glia such as astrocytes, microglia, and oligodendrocytes reside in the CNS, 
Schwann cells and satellite glia are characteristic of the PNS, and the enteric nervous 
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system has to date identified a handful of residential glia types in the gut. There are a few 
characteristics that strongly distinguish glia from their neuronal counterparts. To begin 
with, nerve cells interact with one another and communicate via electrical signaling 
(often referred to as action potentials) and interactions at the synapse, while glia cells 
simply contribute supportive functions in these processes, such as modulating 
neurotransmitter release and uptake and the rate at which signals are propagated along the 
nerve cell[24]. 
 While properties such as these are known to be functions of glia, there are still so 
many more functions that have yet to be discovered. In addition to the variety of these 
cells, their locations and interactions with other cell types make it difficult to pinpoint 
such functions. The most research and attention has thus far been directed towards glia in 
the central nervous system, particularly the brain. In the brain and spinal cord, one of the 
most studied glial cell types is astrocytes. These cells have a very distinct morphological 
structure, leading them to frequently be characterized as star-shaped. Throughout the 
brain, there is an exuberant number of classifications of astrocytes based on morphology 
and location, creating much difficulty in determining the various roles and implications 
of each[25]. Some of the roles of astrocytes consist of regulating blood-brain barrier 
permeability, which is consequential in preventing the entrance of harmful substances 
into the brain, including toxins and bacteria that could cause damage to the brain 
tissue[25]. It has been shown that astrocytes express the same genes as other cell 
progenitors, giving them the ability to be proliferative. This function can have 
implications if proliferation gets out of hand, leading to inflammation of the astrocytes 
which is generally characterized by an upregulation of glial fibrillary acidic protein 
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(GFAP). This inflammation state can sometimes lead to the loss of proper astrocytic 
function, leading to cellular senescence and showing correlations to many 
neurodegenerative diseases, including Alzheimer’s disease, Huntington’s disease, and 
recently exhibiting roles in amyotrophic lateral sclerosis (ALS)[25].  
 Another glial cell type of high importance in the brain and spinal cord is 
microglia. Microglia are notorious for being the “resident macrophages” of the CNS, 
meaning they are crucial to phagocytosis in this region of the body[26]. Phagocytosis is a 
process required for healthy pruning of the brain and includes recognizing, engulfing, and 
digesting foreign, harmful, or unnecessary particles or debris[26]. Not only is this 
function important for the regulation of both innate and adaptive immune responses, but 
it is continuing to prove necessary for modulating pathological processes[27]. The need 
for further research regarding the role of microglia in maintaining a healthy brain versus 
contributing to brain damage remains necessary. Techniques such as using mutant 
rodents or microglial depletion assays are beginning to open up the possibility of such a 
research and have begun showing results indicating that the loss of microglia leads to 
cognitive developmental deficits in rodents[27]. There is even speculation of the role of 
microglia in modulating adult neurogenesis[27].  
 The last of the significant glia trio in the CNS is oligodendrocytes. 
Oligodendrocytes originate from oligodendrocyte precursor cells and are infamous for 
their role in myelination[28]. Oligodendrocytes are able to wrap their branches around 
multiple neuronal axons, which can be an extremely metabolically taxing process, 
leaving these cells susceptible to cytotoxic or excitotoxic infiltration[28]. Affected 
oligodendrocytes can therefore have function alterations that can lead to demyelinating 
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diseases like multiple sclerosis or other pathological diseases like schizophrenia and 
Alzheimer’s disease[28]. 
 While there are three distinguishable categories of glia in the CNS, there are only 
two that are recognized in the PNS – satellite glia cells that reside the ganglia and 
Schwann cells in the peripheral nerves. In rodent models, satellite glia have been shown 
to control cholinergic transmission in sympathetic neuron-to-neuron interactions[29]. 
Satellite glia have also been shown to contribute to overall sympathetic neuronal health 
and survival, in addition to promoting synapse formation[29]. Despite this knowledge, 
there is still much research to be done to further understanding all of the functions of 
satellite glia. Schwann cells, who are often discussed in regards of myelinating peripheral 
nerves, are present in the body in many different developmental stages, correlating them 
to a variety of different roles – many of which still require further research. Lack of 
knowledge about the role of Schwann cells in adipose tissue, their role in nurturing 
neurons, and their communication processes with other cells – particularly immune cells 
– leaves the field with exciting potential for discovery. 
 
Schwann Cell Development 
 Schwann cells are somewhat of an enigma in the peripheral nervous system. 
Although they are notorious for their role in axonal myelination, more and more research 
regarding Schwann cells continues to reveal interesting additions to the responsibilities of 
these cells. The lack of knowledge regarding the wide array of Schwann cell functions 
and communications is invigorating, allowing for the development of innovative avenues 
to study hypotheses of their functions. Extrapolating the relatively little amount of 
 
  13 
information we know about glia in the CNS and hypothesizing how similar roles may be 
carried out in the PNS by Schwann cells could lead to endless new discoveries about the 
importance of this cell group. 
 During embryonic development, the neural crest gives rise to neural crest stem 
cells, which are in turn responsible for giving rise to a multitude of differing sub-lineages, 
including that of Schwann cells[30]. Schwann cell lineage includes many different 
variations of these specialized cells, as can be seen in Figure 1. 
 Schwann Cell Precursors (SCP) are the first developmental stage in Schwann cell 
lineage when beginning to differentiate from neural crest cells. These cells maintain some 
stem-cell-like characteristics after this initial differentiation, allowing them to be 
multipotent, a feature shared amongst early glial cells in both the PNS and CNS[30]. As 
multipotent cells, SCPs also have the ability to differentiate into cells such as 
melanocytes, endoneurial fibroblasts, parasympathetic neurons, chromaffin cells, and 
tooth pulp cells[30]. Additionally, experiments have shown that parasympathetic nerves 
are also capable of being derived from SCPs, giving SCPs a list of differentiation 
possibilities[31,32]. Myelin protein zero (mpz) is a gene that encodes for myelin protein 
zero, notorious for its expression in myelinating Schwann cells. Research has shown, 
however, that mpz is also expressed at low basal levels in Schwann cell lineage long 
before they are differentiated into myelinating Schwann cells, as it has been detected in 
SCPs, immature Schwann cells, and even a small population of neural crest cells before 
axonal outgrowth from the spinal cord has even begun[30]. SCPs are most often 
associated with large nerve branches, in which they embed themselves amongst bundles 
of axons as well as among the axons at the nerve surface. After the conversion of neural 
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crest cells to SCPs in nerves, there is a gene expression change that occurs in hundreds of 
genes – generally an upregulation of functional classes, such as molecules involved in 
cell differentiation and transcription factors[30]. These factors are important, because 
they are often the genes encoding for many of the proteins used to identify Schwann 
cells, such as myelin basic protein (MBP) and desert hedgehog (Dhh), and S100b [30,33]. 
 Next in the Schwann cell lineage are immature Schwann cells. This 
developmental stage occurs during embryonic days 15-16 in mice and shows association 
between these cells, connective tissue, basal lamina inside nerves[30]. Part of the 
Schwann cell membrane is the basil lamina, which surrounds the cell and is responsible 
for housing extracellular matrix molecules, such as laminin[34,35]. In conjugation with 
the laminin receptor, b1-integrin, and other signaling cascades downstream, various 
laminin isoforms work to configure the appropriate alignment of Schwann cells to 
axons[36]. Components of the extracellular matrix regulate function, architecture, and 
function of myelin during the development of Schwann cells[35]. Laminin and its role 
differ throughout Schwann cell lineage, depicting a vital role in stimulation of radial 
sorting. Radial sorting is a process through which immature Schwann cells – originally 
congregated around groups of axons – continue to proliferate so that there is a 1:1 ratio of 
Schwann cells to axons[24,26,27]. Once at this 1:1 ratio, the cells in rodents typically 
become “pro-myelin” cells and go on to form myelinating Schwann cells, but in humans, 
there are a significant number of axons that remain unmyelinated at the 1:1 ratio, 
eventually going on to form Remak bundles, or non-myelin Schwann cells[30].  
 Schwann cell plasma membranes are constituted of a high lipid content and 
cholesterol, playing an important role in the process of myelination[34]. Schwann cells 
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ensheath axons in a methodical manner; the nucleus remains fixed, but the inner turn of 
the Schwann cell membrane creates the myelin sheath by spiraling around the axon to 
continuously build membranous layers, known as lamellae[34]. The amount of 
Neuregulin I-type III exposed on the membrane of the axon sends signals to the Schwann 
cell whether or not it should myelinate, as well as  dictating how much myelin should be 
produced by myelinating Schwann cells[33,37]. Proliferation of Schwann cells occurs 
before cells have gone through radial sorting, as myelinating Schwann cells generally do 
not undergo division. Increased proliferation generally coincides with precursor to 
immature Schwann cell conversion and appears to be correlated to an increase of 
intracellular cAMP[33]. Myelin is unique in its composition of mostly lipids with some 
low-molecular weight proteins, contributing to how densely packed it is[36]. The mere 
structure of myelin indicates that there is likely an unusual form of transport within the 
cell. One of the difficulties in studying this topic in cell biology, is that the myelin is 
packed so tightly that it is difficult to view with light microscopy. Although not the same 
as Schwann cells, oligodendrocytes, the myelinating cells of the CNS, have very similar 
composition to that of Schwann cells, and have been able to be cultured and studied to an 
extent in vivo[36]. Results of culturing oligodendrocytes indicate that vesicle transport is 
confined to the cell body of the cell and doesn’t carry through the layers of myelin 
sheath. Myelin is known to be composed of the cytoplasmic protein myelin basic protein 
(MBP) and proteolipid protein (PLP), the latter of which is an integral protein and may be 
an influential factor in membrane trafficking[38]. 
 Mitochondria and other cytosolic components are located in the outermost layer 
of myelinating Schwann cells. This is termed the abaxonal region and is separated from 
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the region of the cell that is directly attaching to the axon by myelin sheath. Experiments 
indicate that ATP is released from nerve axons, signals to the abaxonal membrane of 
myelinating Schwann cells, and is therefore able to communicate with the mitochondria 
housed there[39]. In fact, extracellular ATP increases with increasing axonal firing and 
leads to activation of purinergic receptors. This is important, as purinergic signaling is 
shown to enhance Schwann cell mitochondrial Ca2+ release, and this increased 
intracellular Ca2+ concentration in the mitochondrial matrix enhances ATP 
production[39]. In Schwann cells during catabolic processes, lactate (that has been 
converted from glycogen) is taken by monocarboxylate transporters, oxidized to 
pyruvate, and then the newly created pyruvate is brought to the axon to join the Krebs 
cycle and produce ATP, just as typical eukaryotic cell metabolism[40]. As research 
continues in this field, indicating the importance of Schwann cell mitochondria in 
myelination and nerve health, there are hypotheses that Schwann cell mitochondrial 
dysfunction could contribute to neuropathic peripheral nerves[41]. 
 Unlike the myelinating cells of the CNS, oligodendrocytes, Schwann cells are not 
fixed once in these states, allowing them a characteristic deemed as plasticity, through 
which these cells are able to convert themselves into regenerative or repair cells in a time 
of injury[42]. These repair cells, deemed “Bungner” cells, are converted to such cells 
from myelinating Schwann cells via the transcription factor c-Jun and reenter the cell 
cycle after injury to help with reparations to injured nerves[43]. The mechanistic 
conversion back into myelinating cells still requires further research, as does the assumed 
role of non-myelinating Schwann cells to also be converted into repair Schwann cells. 
There is continuing research, however, that indicates the role of repair Schwann cells in 
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supporting damaged neurons while promoting axonal regrowth and assisting those axons 
in finding their targets, recruitment of macrophages, and clearing unnecessary 
myelin[44]. Additionally, it is known that Schwann cells are capable of a type of 
autophagy deemed “myelinophagy,” but recent research has also focused on the concept 
of “demyelinating” Schwann cells and their roles in demyelinating neuropathies[45]. 
These cells are believed to play an important role in myelin clearance in conditions both 
with and without intact axons, seeming to play quite similar roles to the repair Schwann 





Figure 1. Schwann cell lineage: from neural crest cell to myelinating and non-
myelinating Schwann cells (Taken from Jessen et. al., 2015; Schwann cells: 
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Immunopanning 
With limited ways of isolating cells and their respective functions, the first 
instance of any sort of “panning” was in the year 1980, and the experiment’s goal was to 
isolate and culture astrocytes from the brain by negatively selecting unwanted immune 
cells[46]. Ben Barres took full advantage of the upcoming technique. He began using it in 
1988 to isolate and purify various cell types from retinal ganglion cells, after which point 
he continued to use it for an extensive number of experiments and published papers[47]. 
This was a successful technique for Barres as it was relatively cheap and quick, while 
providing reliable results. Immunopanning has been a procedure used predominantly in 
the field of neuroscience surrounding the CNS, but has made a few appearances in 
experiments for the PNS. One of the earliest documented isolations of Schwann cells 
through a similar, simple “panning” method was done by Assouline and colleagues in 
1983 with a peripheral nerve taken from a rat model[48]. 
In the experiments conducted for this thesis, the written protocol was adapted 
from one published by Cold Spring Harbor[49]. The protocol from Cold Spring Harbor 
was for isolating Schwann cells from the sciatic nerve – the only peripheral tissue (of any 
kind) to have used immunopanning. Given that the sciatic nerve and adipose tissue are 
quite different in mass, fibrosity, and other constituents, it was necessary for there to be a 
learning curve for adaptations to be made to the protocol. The most eminent part of the 
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Fluorescence-activated Cell Sorting (FACS) 
 One of the most commonly used techniques in separating cell sub-populations 
within a given population is through using fluorescent labeling. Tissues are digested with 
protocols specific to that given tissue and cells are isolated following a protocol. Once the 
cells are isolated, they are labeled with fluorophore-conjugated antibodies that correlate 
to the specific proteins of interest. During sorting, each population of cells (for instance, 
that of adipose taken from one animal) is placed into a flow cytometer. One at a time, the 
cells go to leave the nozzle tip of the machine. As they do so, they enter a single droplet 
that is passed through a laser to detects its fluorescent label and is then given an electric 
charge based on the labeled fluorescence of the cell. In combination with the given 
charges, deflection plates cause cells to either be attracted to or repelled from them and 
into their relative collection tubes [50]. 
 FACS is a very successful and well-practiced method for sorting cells based on 
their phenotypes, but does require the proper, expensive equipment and someone who is 
well versed in using the equipment. Although FACS certainly has its limitations, it is also 
more beneficial in comparison to other techniques, such as magnetic-activated cell 
sorting (MACS), in that the flow cytometry allows more flexibility and accuracy in 
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MATERIALS AND METHODS 
 
I. Experimental Model and Animal Subject Details 
For all immunopanning and FACS experiments, C57BL/6J male and female mice 
(Jackson Laboratory, Bar Harbor, ME; Jax 000664) were used with IACUC approval and 
regulations, as seen in Appendix A. 
 
II. Immunopanning 
Petri dishes were coated with 30 µL of secondary antibody (dish 1: goat anti-rat IgG, 
dish 2: goat anti-mouse IgG + IgM, dish 3: goat anti-mouse IgM, µ chain specific) in 10 
mL of 50mM Tris-HCl. Plates were gently shifted from side to side to allow for the 
bottom surface of each plate to be completely covered with solution and then incubated in 
4ºC overnight. The next morning, the dishes were rinsed three times with D-PBS and a 
solution of 0.2% BSA in D-PBS was added to each dish and left to incubate at room 
temperature. After 30 minutes, the BSA solution was aspirated and each plate was coated 
with their respective primary antibodies (dish 1: CD45, dish 2: Thy1.2, dish 3: O4). The 
plates were left to incubate at room temperature for a minimum of 2 hours. While plates 
were incubating, mice were euthanized by CO2 asphyxiation with secondary cervical 
dislocation. Inguinal scWAT depots were dissected, weighed, and minced in a Petri dish 
containing a collagenase/DMEM (high-glucose, serum-free) solution (concentration of 
2mg/mL). The minced adipose depot was then transferred to a 50 mL conical tube with 
10 mL collagenase/DMEM solution. DRG and sciatic were also dissected and 
collectively pooled into two 15 mL tubes with 3.5 mL collagenase/DMEM solution. The 
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covers of the conical tubes were loosely capped to prevent cell death. The samples were 
placed in a shaking water bath at 37ºC and triturated every 15 minutes with glass pipettes 
of various bores until adipocytes were floating and there were no chunks of tissue 
remaining. Adipose solutions were then filtered into new tubes through 100 µm filters, 
followed by a filter wash of 2 mL low-ovo working solution. Samples were then 
centrifuged at 500g for 10 minutes to pellet the tissue. The collagenase/DMEM cocktail 
was then aspirated out of each tube and replaced with 10 mL of low-ovo working 
solution. Cells were then resuspended in 5 mL of panning buffer, filtered through 100 µm 
cell strainers 1 mL at a time to remove any large pieces of debris, and the filters were 
each washed with an additional 5 mL of panning buffer. Cells were left in 37ºC for 30-45 
minutes to allow for cell recovery. Next, the primary antibodies were aspirated from the 
Petri dishes and the dishes were each washed three times with D-PBS. Samples were 
poured first onto their corresponding CD45 plates and incubated at room temperature for 
20 minutes (lightly shaken at 10 minutes). Non-adherent cells were then transferred from 
their CD45 plate to their Thy1.2 plate and incubated at room temperature for 20 minutes 
(lightly shaken at 10 minutes). Cells that had adhered to the CD45 plate were lifted from 
the plate using 200 µL of 2.5% trypsin in 4 mL of equilibrated EBSS and frozen in 50 µL 
of Trizol Reagent, manually disrupted via trituration, and stored at -80ºC. Non-adherent 
cells were then transferred from their Thy1.2 plate to their O4 plate and incubated at 
room temperature for 20 minutes (lightly shaken at 10 minutes). Cells that had adhered to 
the Thy1.2 plate were lifted from the plate using 200 µL of 2.5% trypsin in 4 mL of 
equilibrated EBSS and frozen in 50 µL of Trizol Reagent, manually disrupted via 
trituration, and stored at -80ºC. Non-adherent cells on the O4 plate were then frozen in 50 
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µL of Trizol Reagent, manually disrupted via trituration, while cells that had adhered to 
the O4 plate were lifted from the plate using 200 µL of 2.5% trypsin in 4 mL of 
equilibrated EBSS and frozen in 50 µL of Trizol Reagent, manually disrupted via 









Figure 2. Schematic of the immunopanning procedure used for these experiments 
 
III. Fluorescence-Activated Cell Sorting (FACS) Analysis 
Mice were euthanized by CO2 asphyxiation with secondary cervical dislocation. 
Inguinal scWAT depots were dissected, weighed, and minced in a Petri dish containing a 
collagenase/DMEM (high-glucose, serum-free) solution (concentration of 2mg/mL). The 
minced adipose depot was then transferred to a 50 mL conical tube with 10 mL 
collagenase/DMEM solution. DRG and sciatic were also dissected and collectively 
pooled into two 15 mL tubes with 3.5 mL collagenase/DMEM solution. The covers of the 
conical tubes were loosely capped to prevent cell death. The samples were placed in a 
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bores until adipocytes were floating and there were no chunks of tissue remaining. 
Samples were then filtered through 100 µm cell strainers into 50 mL tubes and rinsed 
several times with DMEM. The samples were then centrifuged at 500g for 10 minutes to 
separate the adipocytes and SVF. The SVF was collected by aspirating out the solution, 
incubating the pellet in 500 µL of red blood cell (RBC) lysis buffer for 2 minutes on ice. 
Following RBC lysis, 2 mL of DMEM (with serum) was added to stop the lysis and the 
samples were centrifuged at 500g for 5 minutes at 4ºC. DMEM was decanted and cells 
were resuspended in 100 µL FACS buffer (PBS with 5% FCS). Next, 4 µL of FACS 
block per sample and sat on ice for 15-20 minutes. 500 µL of FACS buffer was added 
and samples were spun at 1800 rpm for 5 minutes. Samples were then resuspended in 100 
µL of FACS buffer with FACS antibodies (CD45-AF700, P75-VIOBRIGHT FITC, O4-
APC) for 20 minutes. Cells were then washed 2 times by centrifugation at 1500 rpm for 5 
minutes and resuspended in 300 µL of ice cold FACS buffer. The cells were kept in the 
dark and on ice for the transport to The Jackson Laboratory until the scheduled time of 
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IV. RNA Extraction 
 
For RNA extraction, 2 small scoops of bullet blender beads was added to each 
population of cells in their Safe-lock Eppendorf tubes, which were then paced into the 
Bullet Blender on setting 6 for 3 minutes. Samples were centrifuged at 12,000g for 15 
minutes in a refrigerated centrifuge. The supernatant was pipetted off (avoiding the tissue 
debris and beads) into a new 1.5 mL nuclease-free tube. The tubes sit for 5 minutes at 
room temperature. One volume of ice-cold 95-100% EtOH to each sample and mixed by 
vortexing. Sample was immediately loaded into a labeled column tube and spun at 
12,000g for 30 seconds. The flow-through was discarded into a waste beaker and the 
remainder of the sample was re-run in the same manner until all RNA was bound to the 
column. After the last spin, the column was transferred to a new collection tube and 400 
µL of RNA Pre-Wash buffer was added to the column and spun at 12,000g for 30 
seconds with flow through discarded. This step was then repeated. 700 µL of RNA Wash 
Buffer was added to the column and then spun at 12,000g for 1 minute. Flow-through 
was discarded and the empty column was spun at 12,000g for 2 minutes with the cap 
open to dry the column. The column was transferred to a new 1.5 mL nuclease-free tube 
and 50 µL of nuclease-free water was added directly to the middle of the column. This sat 
for 1-5 minutes on ice to absorb the RNA from the column and spun at 12,000g for 1 
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V. Qubit Analysis 
For high sensitivity RNA measurement with Qubit analysis, Qubit Working Solution for 
all tubes (standards, spike-in, and sample tubes) was prepared by diluting the RNA 
Reagent (200x) into RNA HS Buffer, such that there were 180 µL per sample tube. 180 
µL of Working Solution was pipetted out into two Standard tubes, followed by 10 µL of 
nuclease-free water to each tube and 10 µL of Standard #1 and Standard #2, to their 
respective tubes. Next, Master Mix was prepared by adding Standard #2 (10ng/µL) as our 
spike-in RNA, and nuclease-free water to the tube containing the remaining Qubit 
Working Solution. 199 µL of the Master Mix was aliquoted into each sample tube and 
spike-in control, followed by 1 µL of each RNA sample to its respective sample tube, and 
then 1 µL of nuclease-free water to each respective spike-in control tube. The solution 
was vortexed for a few seconds and then spun down in the centrifuge for a few seconds. 
Tubes were allowed to incubate at room temperature for two minutes in the dark to allow 
the Qubit assay to reach optimal fluorescence. Standardization was first performed in the 
Qubit by first inserting the Standard #1 tube, hitting measure, and then inserting the 
Standard #2 tube and hitting measure. Next, the sample tubes were inserted and measured 
in a recorded order. Values for final RNA levels were determined by putting the data onto 
a flash drive and entering the numbers into an Excel file, where the RNA Spike-in control 
values were able to be subtracted from the final read RNA values, therefore determining 
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VI. Statistical Analysis 
For statistical analysis, statistical calculations were conducted in either Excel or 
GraphPad Prism software (La Jolla, CA, USA), using Student’s t-test and one-way and 
two-way ANOVAs. All plots represent mean +/- SEM. For all figures, *p < 0.05, **p 
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RESULTS 
 
I. Immunopanning Trial I for O4 Positive Cells in subcutaneous white adipose tissue 
At 15 weeks old, four male C57BL/6JUM mice showed no significant difference in 
RNA levels across the cell populations deemed CD45 positive, Thy1.2 positive, O4 
positive, and O4 negative (Fig. 3). RNA levels in all populations were extremely low and 
therefore had to be quantified using Qubit technology rather than Nanodrop. RNA levels 
in the CD45+ population ranged from 0.66 ng/µL – 1.56 ng/µL. RNA levels in the 
Thy1.2+ population ranged from 0.71 ng/µL – 0.97 ng/µL. RNA levels in the O4+ 
population were between 0.44 ng/µL – 1.05 ng/µL. RNA levels in the O4- population 
were between 0.76 ng/µL – 1.24 ng/µL. While there was no statistical significance, it can 
be seen from these numbers that the O4+ population had the smallest number for the low 
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II. Immunopanning Trial II for O4 Positive Cells in subcutaneous white adipose tissue 
At the ages between 13 to 18 weeks, five male C57BL/6JUM mice showed a 
significant difference in RNA levels between the CD45 positive Thy1.2 positive 
populations (Fig. 4). RNA levels were again extremely low across the board, requiring 
analysis by Qubit technology rather than Nanodrop. RNA levels in the CD45+ population 
ranged from 0.65 ng/µL – 3.36 ng/µL. RNA levels in the Thy1.2+ population ranged 
from -0.6 ng/µL (indicating extremely low levels or an error in extraction?) – 0.64 ng/µL. 
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RNA levels in the O4+ population ranged from 0.06 ng/µL – 0.39 ng/µL. RNA levels in 
the O4- population range from 2.51 ng/µL – 8.52 ng/µL. 
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III. Fluorescence-activated cell sorting (FACS) of different cell populations in 
subcutaneous white adipose tissue 
At the ages of 11 and 54 weeks, eight C57BL/6JUM mice were euthanized, and their 
inguinal subcutaneous white adipose depot was digested to isolate the stromal vascular 
fraction (SVF), which was then sorted into various cell populations which were isolated 
through the cell-sorting mechanism known as FACS. When comparing the adipose tissue 
of 11 week old mice to a 54 week old mice, there was a presence of p75+ cells with no 
significant difference between the age groups, a sub-population of cells positive for both 
CD45 and O4 with a statistically significant difference in the CD45+O4+ populations 
between the two age groups, as well as CD45+p75+ and CD45+O4-High sub-populations 
(Fig. 5, 6, 7). Although there were eight possible populations with the combinations of 
the three markers used, only five populations were noted and gated (exclusion of 
CD45+O4+p75+, CD45+O4-p75-, and CD45-O4+p75+ populations). There was a 
statistical significance between mice 11 weeks of age and 54 weeks of age in the cell 
populations labeled CD45+O4+p75- and CD45-O4-p75-. The relationship in the 
CD45+O4+p75- population was a negative correlation with age, while the CD45-O4-
p75- population suggested a relationship that correlated positively with age (Fig. 8A). 
Outliers were included in Figure 8B, but when removed for further comparative analysis, 
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Figure 5. Weight differences between young and aged mice at tissue collection. (A) 
Body weight of mice 11 weeks old compared to body weight of mice 54 weeks old at 
time of tissue collection. (B) Subcutaneous white adipose tissue (scWAT) weight of mice 
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Figure 6. Density plots of the different cell populations represented in a young 
animal. (A) Density plot showing gate for p75+ cell population. (B) Density plot 
showing gate for CD45+O4+ cell population and CD45-O4-High cell population. (C) 
Density plot showing lack of existence of an O4+p75+ cell population. (D) Density plot 
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Figure 7. Density plots of the different cell populations represented in an old animal.  
(A) Density plot showing gate for p75+ cell population. (B) Density plot showing gate 
for CD45+O4+ cell population and CD45-O4-High cell population. (C) Density plot 
showing lack of existence of an O4+p75+ cell population. (D) Density plot showing gate 
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Figure 8. Density plots of the different cell populations represented in sciatic nerve.  
(A) Density plot showing gate for p75+ cell population. (B) Density plot showing gate 
for CD45+O4+ cell population and CD45-O4-High cell population. (C) Density plot 
showing lack of existence of an O4+p75+ cell population. (D) Density plot showing gate 
for CD45+p75+ cell population. 
 
Cell populations expressing only O4, used commonly as a marker of mature 
oligodendroyctes in the CNS and Schwann cells in the PNS, conveyed no statistically 
significant difference between populations of mice aged 11 weeks and those aged 54 
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cell count. Similarly, total cell populations and percent cell counts expressing 
CD45+O4+p75- were measured and compared in mice ages 11 weeks and 54 weeks old 
(Fig. 10). There was a statistically significant decrease in the aged cohort of mice 
compared to the young cohort (Fig. 10B).  
 
             
Figure 9. Population in scWAT expressing only myelin marker O4 in young mice 
compared to aged mice. (A) Total cell population of cells expressing CD45-O4+p75- in 
mice 11 weeks and 54 weeks old. (B) Percent cell count of cells expressing CD45-
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Figure 10. Population in scWAT expressing myelin marker O4 and common 
leukocyte marker CD45 in young mice compared to aged mice. (A) Total cell 
population of cells expressing CD45+O4+p75- in mice 11 weeks and 54 weeks old. (B) 




As a categorical marker of Schwann cells throughout their developmental lineage, 
p75 showed expression in two different populations (Fig. 11). Comparisons were done 
for both the total cell population and the percent cell count of CD45+O4-p75+ (Fig. 11A, 
11B). Similarly, total cell populations and percent cell counts expressing CD45-O4-p75+ 
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Figure 11. Populations of cells in scWAT expressing p75. (A) Total cell population of 
cells expressing CD45+O4-p75+ in mice 11 weeks and 54 weeks old. (B) Percent cell 
count of cells expressing CD45+O4-p75+ in mice 11 weeks and 54 weeks old. (C) Total 
cell population of cells expressing CD45-O4-p75+ in mice 11 weeks and 54 weeks old. 
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The five cell populations were plotted relative to body weight. The two 
populations that showed statistical significance were again, the CD45+O4+p75- 
population and CD45-O4-p75- population; the former showing a negative correlation 
with percentage of total cells to body weight and the latter showing a positive correlation 






















Figure 12. Correlation between population cell percentage and body weight. 
(A)  The correlation between the CD45+O4-p75+ population cell percentage and body 
weight. (B) The correlation between the CD45+O4+Pp5- population cell percentage and 
body weight. (C) The correlation between the CD45-O4+p75- population cell percentage 
and body weight. (D) The correlation between the CD45-O4-p75+ population cell 
percentage and body weight, and (E) The correlation between the CD45-O4-p75- 
population cell percentage and body weight. 




















CD45+O4-P75+ Cell Percent vs Body Weight
Y = -0.09883*X + 11.72
R2 = 0.1560
P=0.3328




















CD45-O4+P75-Cell Percent vs Body Weight
Y = -0.05019*X + 3.738
R2 = 0.2351 
P=0.2233






















CD45-O4-P75-Cell Percent vs Body Weight
Y = 1.336*X + 12.81
R2 = 0.5690 
P=0.0306





















CD45+O4+P75-Cell Percent vs Body Weight
Y = -1.177*X + 70.25
P=0.0256
R2 = 0.5920 





















CD45-O4-P75+Cell Percent vs Body Weight
Y = -0.01203*X + 1.533
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          The five cell populations were also plotted relative to adipose weight. The only 
population that showed statistical significance in these plots was the CD45+O4+p75- 
population. This population showed a negative correlation between percentage of total cells 
















Figure 13. Correlation between population cell percentage and adipose weight. 
(A)  The correlation between the CD45+O4-p75+ population cell percentage and adipose 
weight. (B) The correlation between the CD45+O4+p75- population cell percentage and 
adipose weight. (C) The correlation between the CD45-O4+p75- population cell 
percentage and adipose weight. (D) The correlation between the CD45-O4-p75+ 
population cell percentage and adipose weight, and (E) The correlation between the CD45-
O4-p75- population cell percentage and adipose weight. 
 
 




















CD45+O4-P75+ Cell Percent vs Adipose Weight
Y = -1.952*X + 8.660
P=0.05381
R2 = 0.06631 




















CD45-O4+P75-Cell Percent vs Adipose Weight
Y = -1.565*X + 2.424
R2 = 0.2491
P=0.2080




















CD45-O4-P75-Cell Percent vs Adipose Weight
Y = 36.43*X + 49.96
P=0.0642
R2 = 0.4608 






















CD45+O4+P75-Cell Percent vs Adipose Weight
Y = -32.80*X + 37.84
R2 = 0.5011 
P=0.0495





















CD45-O4-P75+Cell Percent vs Adipose Weight
Y = -0.1792*X + 1.137
P=0.08592
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DISCUSSION 
 
 While there is still an exorbitant amount of information that remains unanswered 
about the mechanisms and roles of Schwann cells, there is even less information about 
their roles in adipose tissue and therefore a lack of knowledge regarding implications of 
the presence (or lack thereof) of Schwann cells in neuropathy in the subcutaneous 
adipose depot. The phenotypic plasticity of Schwann cells constitutes their continuation 
as an enigma in the peripheral nervous system, although researchers are slowly chipping 
away at their various developmental stages, phenotypes, and associated roles and 
molecular markers[33]. White adipose tissue is characteristically known for its role in 
energy storage and for adipocytes being the major cellular constituent of the tissue. Only 
recently has the importance of subcutaneous WAT and its innervation been recognized 
for its role in peripheral neuropathy[17]. As this has been recent discussion, there hasn’t 
been much focus – or any, really – on the existence of Schwann cells in adipose tissue 
and their role in nerve health in these depots. 
 
Immunopanning 
 Such low levels of RNA extracted from all cell populations in immunopanning 
trials I and II are likely a result of there not being a large number of cells in each 
population present in adipose tissue taken from a singular animal. While the left and right 
depots were pooled, the depots from each individual animal were analyzed separately for 
integrity. The extremity to which the RNA levels were low requires RNA amplification 
before conversion to cDNA for analysis via quantitative polymerase chain reaction 
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(qPCR) can occur. Finding an RNA amplification kit that works for the samples taken 
and that is compatible with downstream Green SYBR chemistry for qPCR proved to be a 
bit of a hassle. qPCR is a necessary technique that allows the samples to be analyzed for 
gene expression of various genes. The major goal of this is two-fold; to ensure the cell 
population isolated on each dish were congruent with what was anticipated, and to see 
what characteristic markers of Schwann cells were expressed by the O4+ population, as 
that population was anticipated to be solely Schwann cells. While there is a presence of 
O4+ cells in both immunopanning trials I and II, it would be preemptive to claim solely 
from this data that this population is Schwann cells. Also, it is important to note that 
results from immunopanning trial II are more reliable for the reason that the collagenase 
used in immunopanning trial I didn’t digest the tissue as well as we had hoped, so we 
switched to collagenase A in the second trial and had much better luck with the digestion 
of the adipose tissue.  
 
FACS 
 The antibodies chosen for the FACS experiments were done so strategically. The 
marker p75 is notorious for its role in marking both Schwann cell precursors (SCPs) and 
non-myelinating Schwann cells, or Remak cells, as well as sometimes being used as a 
marker of Schwann cells in general [52–54]. As seen in Figure 11, there was a presence 
of a CD45+p75+ cell population as well as a solely p75+ cell population. Interestingly, 
there was cell population that we gated indicating an overlapping presence of both of the 
markers for O4 and p75. This is an intriguing note, as both have been used as markers for 
mature Schwann cells in literature, yet there appears to be no overlapping population in 
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the adipose tissues taken from the mice in this experiment. This could be indicative of a 
niche population solely expressing p75 or one expressing both p75 and the common 
leukocyte marker CD45. There was, however, a surprisingly low number of p75 cells. 
This information combined with the lack of p75+/O4+ overlap, may suggest the need to 
look at other antibody options, as some antibodies are tissue specific and therefore work 
better in some tissues than others. When comparing the two age populations (mice at 11 
weeks versus mice at 54 weeks), there was no statistically significant difference. This 
indicates that age may not be an important factor in the number of SCPs or non-
myelinating Schwann cells present in the inguinal subcutaneous white adipose tissue. 
Debatably, as age is historically a causative agent of peripheral neuropathy, these two 
Schwann cell phenotypes may not be critical to preventing peripheral neuropathy and 
maintaining nerve health in this manner.  
There was also a sub-population of cells identified to be only O4+. 
Oligodendrocyte marker 4 (O4) was chosen as a marker for myelinating Schwann cells. 
Oligodendrocytes are the myelinating cell of the CNS and are quite similar to Schwann 
cells in that regard. Therefore, O4 was previously used in the Cold Spring Harbor 
protocol referenced for isolating and purifying Schwann cells, and is used throughout the 
literature for marking myelinating Schwann cells[49,55]. The presence of O4+ cells does 
further reiterate our findings from the immunopanning trials that there are myelinating 
cells in these tissues. While these cells appear to have a negative trend with age, there is 
no significant difference in total cell percentage between age groups. Comparatively to 
the CD45+O4+ sub-population, this sub-population of exclusively O4+ cells constitutes a 
miniscule percentage of the entire cell population.  
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The sub-population of cells sorted that commands the most attention is that of the 
CD45+O4+. Cluster of differentiation 45 (CD45) is a known common leukocyte marker. 
This is of interest, because leukocytes are responsible for the body’s immune response 
through a widespread variety of mechanisms. Distinguishing cells with this marker is 
critical, as the role of Schwann cells in immune responses is still being researched 
intensely. Schwann cells are known for both their ability to recruit high levels of 
leukocytes, such as macrophages and neutrophils, post-injury, as well as their ability to 
change phenotypically to help in the axonal repair process[45,52,53]. During the sort, the 
CD45+O4+ quickly became the most intriguing subset of cells. These cells both 
expressed a marker well known for marking myelination, but also a very typical marker 
of immune cells. These results indicate that there is a phenotypic population of cells 
expressing proteins typically concurrent with myelination, that are also expressing the 
same proteins as many leukocytes. This is a very interesting finding, as it reiterates the 
potential role of Schwann cells (or Schwann-like cells) in immunity and repair. 
Additionally, this population was the only population (aside from that reading negative to 
all markers), that had a significant difference between age groups. Mice at the age of 11 
weeks showed a significantly higher percentage of total cells that were CD45+O4+ when 
compared to mice at the age of 54 weeks. As mentioned before, aging is a common 
trigger for peripheral neuropathy, indicative of a correlation to declining nerve health. 
There are also many neuropathies that develop as a result of demyelination [45]. The 
significant decline in total cell percentage of cells that are CD45+O4+ is extremely 
intriguing, as this is a group of cells previously unidentified to our knowledge. To further 
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identify what these cells may be and their potential role in adipose and/or nerve health, 
we must use qPCR to confirm gene expression.   
Another intriguing difference to note is that in the sub-population of cells that 
were negative for all markers, there was a statistical significance between age groups. In 
this scenario, however, the opposite difference from the CD45+O4+ sub-population was 
found, and the total percentage of cells that were negative for all markers increased 
significantly with age. A hypothesis to consider is that as individuals age and cells 
become senescent, they stop exhibiting the proteins responsible for immune responses 
and myelination, and therefore fall into a category of no expression.  
In Figures 12 and 13, the total cell percentages of each sub-population were 
graphed relative to body weight (Fig. 12) and adipose weight (Fig. 13). Figure 12B shows 
a statistically significant negative correlation between body weight (g) and total 
percentage of CD45+O4+ cells. This finding carries over to Figure 13B, showing a 
statistically significant negative correlation between adipose weight (g) and total 
percentage of CD45+O4+ cells. Together, these results indicate that as body weight and 
adipose weight increase, the number of CD45+O4+ cells decrease. This is relevant when 
considering implications of the obesity epidemic. Literature shows that increased obesity 
leads to many co-morbidities, including those previously listed in this thesis. If this sub-
population of cells (CD45+O4+) is critical for playing a role in maintaining nerve health, 
this data would suggest that as individuals become more obese, they are more likely to 
have a low percentage of these cells, and therefore are likely to have decreased 
maintenance of nerve health in adipose tissue. Furthermore, obesity is defined by a larger 
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fat mass, so the increased amount of fat would be pertinent to the fact that these cells 
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FUTURE DIRECTIONS 
 
 Now that the immunopanning protocol has had most of its kinks worked out, 
further experiments can be conducted using the developed protocol. Upon arrival of the 
RNA amplification kit in the Townsend Lab, the RNA from both immunopanning trials 
and FACS experiments can be amplified and converted into cDNA, at which point the 
gene expression of the differing cell populations can be confirmed using primers we have 
already designed for qPCR. Once the cell types in these populations are confirmed, 
further conclusions can be drawn – from the immunopanning trials particularly.  
 Additionally, other antibodies can be used in the immunopanning protocol to 
isolate different cell populations and speculate for previously unidentified ones. For 
instance, there may be populations of cells exhibiting markers characteristic of other glia 
or immune cell types that have yet to identified in adipose tissue. Emerging glial cells and 
their respective roles are becoming apparent in areas such as the enteric nervous system, 
so speculating the possibility of similar cell types residing in the adipose tissue and 
playing an imperative role in nerve health is not unrealistic.  
Furthermore, FACS can continue to be used as way to sort live cell populations. 
Further studies should include valid young vs. aged cohort of females and one of males to 
compare potential sex differences. Other interventions of interest that may show 
important effects on adipose tissue are that of a high-fat diet and a cold versus room 
temperature, respectively. As the FACS experiment in this thesis indicates a correlation 
between adipose weight and sub-population of cells, it would be of interest to induce 
obesity through a high-fat diet and compare sub-populations (such as that of CD45+O4+) 
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in these mice relative to healthy mice. We have also seen that cold interventions exhibit 
an increase in GAP43, a marker that indicates axonal cone outgrowth[17]. It would be 
interesting to see how cell populations change over time based on cold exposure. If 
axonal cone outgrowth increases in the cold and if cell sub-populations, such as 
CD45+O4+, prove critical for nerve health or repair, it may be hypothesized that sub-
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